These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Studies in clinical shock and hypotension. V. Hemodynamic effects of dextran. Cohn JN; Luria MH; Daddario RC; Tristani FE Circulation; 1967 Feb; 35(2):316-26. PubMed ID: 6024300 [No Abstract] [Full Text] [Related]
4. The physiologic basis for treatment of shock associated with myocardial infarction. Gunnar RM; Pietras RJ; Stavrakos C; Loeb HS; Tobin JR Med Clin North Am; 1967 Jan; 51(1):69-81. PubMed ID: 4869243 [No Abstract] [Full Text] [Related]
5. Hypovolemia in shock due to acute myocardial infarction. Loeb HS; Pietras RJ; Tobin JR; Gunnar RM Circulation; 1969 Nov; 40(5):653-9. PubMed ID: 5377207 [No Abstract] [Full Text] [Related]
6. The treatment of myocardial infarction with low molecular weight dextran. Langsjoen PH; Sanchez SA; Lynch DJ; Inmon TW Am Heart J; 1968 Jul; 76(1):28-34. PubMed ID: 5659273 [No Abstract] [Full Text] [Related]
8. [Use of adrenergic alpha receptor blockaders in patients with myocardial infarct in the state of shock]. Gratsianskiĭ NA Kardiologiia; 1970 Sep; 10(9):39-53. PubMed ID: 4395961 [No Abstract] [Full Text] [Related]
9. [Cardiogenic shock and severe hypotension in acute myocardial infarct treated with glucagon. Preliminary experience from a coronary unit]. Amtorp O; Christiansen I; Wennevold A Ugeskr Laeger; 1971 May; 133(18):867-70. PubMed ID: 5577747 [No Abstract] [Full Text] [Related]
10. Indications for adrenergic stimulators in shock. Mills LC; Moyer JH Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):385-95. PubMed ID: 5566718 [No Abstract] [Full Text] [Related]
11. Clinical experience with low molecular weight dextran in acute myocardial infarction. Langsjoen PH J Miss State Med Assoc; 1969 Nov; 10(11):499-502. PubMed ID: 5352795 [No Abstract] [Full Text] [Related]
12. [Low-molecular dextran in the treatment of cardiogenic shock]. Dyduszyński A Pol Tyg Lek; 1969 Jul; 24(27):1059-61. PubMed ID: 5805885 [No Abstract] [Full Text] [Related]
13. [Surgery without blood transfusion, with special reference to low molecular dextran]. Iryo; 1968 Jul; 22(7):797-802. PubMed ID: 5702010 [No Abstract] [Full Text] [Related]
15. Reversal of hypotension with naloxone. Higgins TL; Sivak ED Cleve Clin Q; 1981; 48(2):283-8. PubMed ID: 7296869 [No Abstract] [Full Text] [Related]
16. [Methylprednisolone in the complex theapy of shock in myocardial infarct]. Gratsianskiĭ NA Kardiologiia; 1970 Dec; 10(12):45-53. PubMed ID: 5507776 [No Abstract] [Full Text] [Related]
17. Cardiogenic shock treated with infusion of dextrose solution. Nixon PG; Ikram H; Morton S Am Heart J; 1967 Jun; 73(6):843-5. PubMed ID: 6026048 [No Abstract] [Full Text] [Related]
18. [Dextran 40,000 in the treatment of shock in myocardial infarct]. Sadowski Z; Giec L; Luczak J; Bielak J Pol Tyg Lek; 1975 Mar; 30(12):519-22. PubMed ID: 1118345 [No Abstract] [Full Text] [Related]
19. Studies in clinical shock and hypotension. 3. Comparative effects of vasopressor drugs and dextran. Cohn JN; Luria MH Arch Intern Med; 1965 Oct; 116(4):562-6. PubMed ID: 4284276 [No Abstract] [Full Text] [Related]
20. [Acid-base state in patients with myocardial infarct complicated by shock]. Teplova NN Kardiologiia; 1969 Mar; 9(3):26-34. PubMed ID: 5361935 [No Abstract] [Full Text] [Related] [Next] [New Search]